Clarivate (United States)

Clarivate (United States)

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Clarivate (United States), United States, covering academic research published from 2016 to 2024. Read More.


Open Access Percentage

51%


Total
Publications

118


Total Open
Publications

60


Total
Citations

2.2K


Open Access
Percentage

51%


Total
Publications

118


Total Open
Publications

60


Total
Citations

2.2K

Wikipedia

Website

download

Breakdown

18% 24% 6% 52%

Publisher Open

18%

Both

24%

Other Platform Open

6%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
201620172018201920202021202220232024

Open

Closed

Publisher Open

40%OA Journal

OA Journal 40%

19

Hybrid 43%

20

No Guarantees 17%

8

Other Platform Open

Domain 76%

25

Institution 24%

8

Preprint 12%

4

Other Internet 12%

4

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
24
DOI
Other Internet
4
Research Square
Preprint
3
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
3
Europe PMC
Domain
3
The University of Kansas - KU ScholarWorks
Institution
2
USMAI Consortium - Maryland Shared Open Access Repository
Institution
1
University of Barcelona - Revistes Científiques de la University of Barcelona
Institution
1
Leibniz Universität Hannover - Institutional Repository of Leibniz Universität Hannover
Institution
1
Digital Access to Libraries
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share